• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8/4/25 4:25:49 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    alb-20250730
    false000091591300009159132025-07-302025-07-300000915913us-gaap:CommonStockMember2025-07-302025-07-300000915913us-gaap:SeriesAPreferredStockMember2025-07-302025-07-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _________________________________
    FORM 8-K
    _________________________________

    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): July 30, 2025

    _________________________________
    ALBEMARLE CORPORATION
    (Exact name of registrant as specified in charter)
    _________________________________
    Virginia001-1265854-1692118
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    4250 Congress Street, Suite 900
    Charlotte, North Carolina 28209
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (980) 299-5700
    Not applicable
    (Former name or former address, if changed since last report.)
    _________________________________

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    COMMON STOCK, $.01 Par ValueALBNew York Stock Exchange
    DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred StockALB PR ANew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On July 30, 2025, Albemarle Corporation (the “Company”) and J. Kent Masters, the Company’s President and Chief Executive Officer and Chairman of the Board, entered into an Amended and Restated Executive Employment Agreement (the “New Employment Agreement”) and an Amended and Restated Severance Compensation Agreement (the “New Change in Control Agreement”). The New Employment Agreement amends and restates the Amended and Restated Employment Agreement, dated March 15, 2023, between Mr. Masters and the Company (the “Original Employment Agreement”). The New Change in Control Agreement amends and restates the Amended and Restated Severance Compensation Agreement, dated March 15, 2023, between Mr. Masters and the Company (the “Original Change in Control Agreement”).

    The New Employment Agreement extends Mr. Masters’ employment as the Company’s President and Chief Executive Officer through March 30, 2027, unless sooner terminated pursuant to its terms. The Board of Directors has elected to extend Mr. Masters’ employment given his extensive leadership and industry expertise providing continuity as the Company continues to navigate a successful restructuring and a dynamic period for the industries the Company serves.

    Mr. Masters will continue to receive an annual base salary of $1,400,000 and will continue to be eligible for an annual bonus under the Company’s annual incentive plan with a target amount of 150% of his annual base salary and a maximum amount of 200% of his target amount.

    Mr. Masters will be eligible for annual grants of long-term incentive awards under the Company’s long term incentive program in 2026 (the “2026 LTI Grants”). Time-based 2026 LTI Grants will vest on March 30, 2027, subject to Mr. Masters’ continued employment through such date. Performance-based 2026 LTI Grants will require continued employment through March 30, 2027, and will vest at the end of the applicable performance period based on the actual level of performance goals achieved.

    If Mr. Masters’ employment is terminated upon (i) expiration of the term of the New Employment Agreement or (ii) the appointment of a successor CEO prior to such expiration, in each case, other than for “cause” (as defined in the New Employment Agreement) and outside of a change of control protection period, Mr. Masters will receive, subject to his execution of a release of claims in favor of the Company and his compliance in all material respects with all applicable restrictive covenants in the New Employment Agreement and any other agreement with the Company, (i) his accrued benefits, (ii) an annual bonus based on actual level of performance (prorated for the number of days employed if such termination occurs in 2027), (iii) if such termination occurs in 2026, an amount equal to the base salary he would have received through the end of 2026, (iv) continued vesting of the 2026 LTI Grants (as described above) and (v) financial counseling. If Mr. Masters’ employment is terminated under circumstances that would have resulted in accelerated vesting of the 2026 LTI Grants pursuant to the Original Employment Agreement, such vesting will be contingent on his continued compliance in all material respects with all applicable restrictive covenants in the New Employment Agreement and any other agreement with the Company through March 30, 2027. The New Employment Agreement includes non-competition and non-solicitation covenants for a three-year post-employment period.

    The New Change in Control Agreement extends the term of the Original Change in Control Agreement through March 30, 2027, unless sooner terminated pursuant to its terms. The New Employment Agreement and the New Change in Control Agreement contain other terms substantially similar to the terms of the Original Employment Agreement and the Original Change in Control Agreement, respectively.



    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ALBEMARLE CORPORATION
    Date: August 4, 2025By:/s/ Ander C. Krupa
    Ander C. Krupa
    Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer


    Get the next $ALB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    7/30/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    7/29/2025$60.00Neutral → Underperform
    Robert W. Baird
    7/11/2025$57.00Neutral → Sell
    UBS
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    More analyst ratings

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Gagarinas Autumn M. claimed ownership of 4,054 shares (SEC Form 3)

    3 - ALBEMARLE CORP (0000915913) (Issuer)

    8/21/25 4:18:32 PM ET
    $ALB
    Major Chemicals
    Industrials

    General Counsel & Sec Krupa Ander C. was granted 7,430 shares, increasing direct ownership by 171% to 11,771 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    8/8/25 4:16:45 PM ET
    $ALB
    Major Chemicals
    Industrials

    New insider Krupa Ander C. claimed ownership of 4,341 shares (SEC Form 3)

    3 - ALBEMARLE CORP (0000915913) (Issuer)

    8/8/25 4:16:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units

    Commercial trial demonstrates SaFeGuard's™ effectiveness in processing opportunity crudes Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing has launched SaFeGuard™, a new catalyst technology designed to address iron (Fe) poisoning in FCC units. In a recent 30-day full commercial trial, SaFeGuard™ demonstrated a 77% improvement in accessibility with a 50% inventory replacement enabling an increase in unit activity, improved bottoms cracking, and ability to process heavy iron-rich feedstocks. Further testing and predictive modeling suggest that a full 100% inventory changeout could yield up to a 130% increase in accessibility delivering additional improvement in

    8/20/25 12:02:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Enhanced Organizational Structure

    Aligns the company's functional model for greater agility and efficiency and is designed to accelerate market-led growth and operational excellence CHARLOTTE, N.C., Aug. 11, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of to

    8/11/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces New General Counsel, Corporate Secretary and Chief Compliance Officer

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary and chief compliance officer. "Ander's demonstrated leadership, broad legal expertise, and deep institutional knowledge positions him well to assume strategic oversight of Albemarle's legal, ethics, risk, and compliance functions," said Kent Masters, Albemarle's Chairman and CEO. "We are c

    7/30/25 4:30:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Albemarle from Overweight to Sector Weight

    7/30/25 7:24:56 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Albemarle from Neutral to Underperform and set a new price target of $60.00

    7/29/25 7:36:15 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle downgraded by UBS with a new price target

    UBS downgraded Albemarle from Neutral to Sell and set a new price target of $57.00

    7/11/25 8:09:46 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    SEC Filings

    View All

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    8/12/25 4:32:46 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    8/5/25 11:11:06 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    8/4/25 4:25:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Reports Second Quarter 2025 Results

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2025. Second-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.3 billion, including volume growth in Energy Storage (+15%) and Specialties (+6%).Net income of $23 million, or ($0.16) per diluted share attributable to common shareholders; adjusted diluted

    7/30/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., July 22, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect wit

    7/22/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

    CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

    6/18/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

    CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

    8/2/23 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials